Bad cholesterol slashed 62% by single dose of gene-editing drug in small trial
The interim Phase I trial data was only from 35 people, but results look good so far.
The interim Phase I trial data was only from 35 people, but results look good so far.
Detalles clave
- Fuente confiable
- Actualizado recientemente
- Impacto relevante
Fuente: Leer artículo original